Use of complementary medicine products: a nationally representative cross-sectional survey of 2019 Australian adults
- PMID: 31315853
- PMCID: PMC6661602
- DOI: 10.1136/bmjopen-2018-024198
Use of complementary medicine products: a nationally representative cross-sectional survey of 2019 Australian adults
Erratum in
-
Correction: Use of complementary medicine products: a nationally representative cross-sectional survey of 2019 Australian adults.BMJ Open. 2019 Aug 15;9(8):e024198corr1. doi: 10.1136/bmjopen-2018-024198corr1. BMJ Open. 2019. PMID: 31420403 Free PMC article. No abstract available.
Abstract
Objectives: To provide a contemporary description of complementary medicine (CM) product use in Australia.
Design: Cross-sectional survey.
Setting: Online.
Participants: A nationally representative sample (n=2019) of the Australian adult population.
Primary and secondary outcome measures: Primary outcomes measures included the use and type of CM products used, and source of recommendation. Secondary measures included disclosure of CM product use to health practitioners, concomitant use of pharmaceuticals and predictors of use.
Results: Prevalence of CM product use was 50.3%, with the most frequently used being vitamin and mineral supplements (VMSs; 47.8%) and homoeopathic medicines the least used (6.8%). A majority of respondents using CM products were also using pharmaceutical products, and small but significant associations were found between the use of CM products and pharmaceuticals (p<0.05). Small statistically significant associations were found between use of vitamin products and disclosure of use to general practitioners (GPs; Cramer's V=0.13, p=0.004) and hospital doctors (Cramer's V=0.11, p=0.04), and between use of herbal medicines and disclosure to both GPs (Cramer's V=0.11, p=0.02) and hospital doctors (Cramer's V=0.12, p=0.03). Women, those with higher education and those with no private health insurance were more likely to use CM products (p<0.05), while those without chronic conditions were less likely to use CM products (p<0.05) (χ2(29)=174.70, p<0.001).
Conclusions: The number of Australians using CM products has remained relatively stable and substantial for nearly two decades. The majority of CM use relates to VMSs. Given the number of Australians using both CM products and pharmaceutical medicines, it is important to evaluate the potential clinical implications of such practices to ensure safe, effective and coordinated health policy and patient care.
Keywords: complementary medicines; nutrition and dietetics; primary care; public health.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Cushingoid features and adrenal insufficiency from herbal supplement consumption: alerts released from the Therapeutic Goods Administration and Medsafe.Intern Med J. 2023 Apr;53(4):656-657. doi: 10.1111/imj.16070. Intern Med J. 2023. PMID: 37186362 No abstract available.
References
-
- Coulter ID, Willis EM. The rise and rise of complementary and alternative medicine: a sociological perspective. Med J Aust 2004;180:587–90. - PubMed
-
- The Australian Government. The Therapeutic Goods Administration, Complementary Medicine Regulation, 2018: Canberra. Australia https://www.tga.gov.au/complementary-medicines (accessed 31st July 2018).
-
- The World Health Organisation. WHO traditional medicine strategy: 2014-2023. Geneva Switzerland: World Health Organisation, 2014:76.
-
- World Health Organization. Fact sheet N°134: Traditional medicine. http://www.who.int/mediacentre/factsheets/fs134/en/print.html.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical